Biolase, Inc. (BIOL) - Financial and Strategic SWOT Analysis Review
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Biolase, Inc. (BIOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Biolase, Inc. (Biolase) is medical device company which develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners; in-office, chair-side milling machines; and three-dimensional (3D) printers. The company offers two categories of laser system products: WaterLase systems and Diode systems. Its products include Waterlase iPlus, WaterLase MDX and Waterlase MD Turbo, Epic and iLase. The companys products find applications in minimally invasive dental procedures, such as cosmetic, restorative and complex surgical applications. Biolase offers these products to dentists, periodontists, endodontists, oral surgeons and other dental specialists. Biolase distributes its products through direct sales force, agents and distributors. The company has operations in Americas, Europe, the Middle East and Asia-Pacific. Biolase is headquartered in California, the US.
Biolase, Inc. Key Recent Developments
May 05,2017: BIOLASE Announces Management Change
May 03,2017: BIOLASE Reports 2017 First Quarter Results
Mar 13,2017: BIOLASE Names James D. Surek Vice President Sales, Americas
Mar 08,2017: BIOLASE Reports 2016 Full Year and Fourth Quarter Results
Mar 01,2017: BIOLASE Names Mark J. Nelson Chief Financial Officer
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Biolase, Inc. (Biolase) is medical device company which develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners; in-office, chair-side milling machines; and three-dimensional (3D) printers. The company offers two categories of laser system products: WaterLase systems and Diode systems. Its products include Waterlase iPlus, WaterLase MDX and Waterlase MD Turbo, Epic and iLase. The companys products find applications in minimally invasive dental procedures, such as cosmetic, restorative and complex surgical applications. Biolase offers these products to dentists, periodontists, endodontists, oral surgeons and other dental specialists. Biolase distributes its products through direct sales force, agents and distributors. The company has operations in Americas, Europe, the Middle East and Asia-Pacific. Biolase is headquartered in California, the US.
Biolase, Inc. Key Recent Developments
May 05,2017: BIOLASE Announces Management Change
May 03,2017: BIOLASE Reports 2017 First Quarter Results
Mar 13,2017: BIOLASE Names James D. Surek Vice President Sales, Americas
Mar 08,2017: BIOLASE Reports 2016 Full Year and Fourth Quarter Results
Mar 01,2017: BIOLASE Names Mark J. Nelson Chief Financial Officer
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
TABLE OF CONTENTS
Section 1 - About the Company 6
Biolase, Inc. - Key Facts 6
Biolase, Inc. - Key Employees 7
Biolase, Inc. - Key Employee Biographies 8
Biolase, Inc. - Key Operational Employees 9
Biolase, Inc. - Major Products and Services 10
Biolase, Inc. - Medical Equipment Pipeline Products Data 12
Biolase, Inc. Pipeline Products by Equipment Type 12
Biolase, Inc. Pipeline Products by Development Stage 13
Biolase, Inc. - History 15
Biolase, Inc. - Company Statement 19
Biolase, Inc. - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Section 2 Company Analysis 22
Biolase, Inc. - Business Description 22
Biolase, Inc. - Corporate Strategy 23
Biolase, Inc. - SWOT Analysis 24
SWOT Analysis - Overview 24
Biolase, Inc. - Strengths 24
Biolase, Inc. - Weaknesses 25
Biolase, Inc. - Opportunities 26
Biolase, Inc. - Threats 27
Biolase, Inc. - Key Competitors 28
Section 3 Company Financial Ratios 29
Financial Ratios - Capital Market Ratios 29
Financial Ratios - Annual Ratios 30
Performance Chart 32
Financial Performance 32
Financial Ratios - Interim Ratios 33
Financial Ratios - Ratio Charts 34
Section 4 Companys Lifesciences Financial Deals and Alliances 35
Biolase, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 35
Biolase, Inc., Medical Equipment, Deals By Type, 2011 to YTD 2017 36
Biolase, Inc., Recent Deals Summary 37
Section 5 Companys Recent Developments 38
May 05, 2017: BIOLASE Announces Management Change 38
May 03, 2017: BIOLASE Reports 2017 First Quarter Results 39
Mar 13, 2017: BIOLASE Names James D. Surek Vice President Sales, Americas 41
Mar 08, 2017: BIOLASE Reports 2016 Full Year and Fourth Quarter Results 42
Mar 01, 2017: BIOLASE Names Mark J. Nelson Chief Financial Officer 44
Jan 09, 2017: BIOLASE Announces Management Change 45
Nov 08, 2016: BIOLASE Reports 2016 Third Quarter and Nine-Month Results 46
Oct 31, 2016: BIOLASE Names Samuel B. Low, D.D.S., M.S., M.Ed., Vice President, Dental and Clinical Affairs & Chief Dental Officer 48
Sep 22, 2016: BIOLASE Names Holger Arens Vice President, Managing Director EMEA 49
Aug 01, 2016: BIOLASE Reports 2016 Second Quarter and Six-Month Results 50
Section 6 Appendix 52
Methodology 52
Ratio Definitions 52
About GlobalData 56
Contact Us 56
Disclaimer 56
List Of Tables
Biolase, Inc., Key Facts 6
Biolase, Inc., Key Employees 7
Biolase, Inc., Key Employee Biographies 8
Biolase, Inc., Key Operational Employees 9
Biolase, Inc., Major Products and Services 10
Biolase, Inc. Pipeline Products by Equipment Type 12
Biolase, Inc. Number of Pipeline Products by Development Stage 13
Biolase, Inc. Pipeline Products Summary by Development Stage 14
Biolase, Inc., History 15
Biolase, Inc., Other Locations 20
Biolase, Inc., Subsidiaries 20
Biolase, Inc., Key Competitors 28
Biolase, Inc., Ratios based on current share price 29
Biolase, Inc., Annual Ratios 30
Biolase, Inc., Annual Ratios (Cont...1) 31
Biolase, Inc., Interim Ratios 33
Biolase, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 35
Biolase, Inc., Medical Equipment, Deals By Type, 2011 to YTD 2017 36
Biolase, Inc., Recent Deals Summary 37
Currency Codes 52
Capital Market Ratios 52
Equity Ratios 53
Profitability Ratios 53
Cost Ratios 54
Liquidity Ratios 54
Leverage Ratios 55
Efficiency Ratios 55
List Of Figures
Biolase, Inc. Pipeline Products by Equipment Type 12
Biolase, Inc. Pipeline Products by Development Stage 13
Biolase, Inc., Performance Chart (2012 - 2016) 32
Biolase, Inc., Ratio Charts 34
Biolase, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 35
Biolase, Inc., Medical Equipment, Deals by Type, 2011 to YTD 2017 36
RELATED REPORTS
SAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
